An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease

Status:
Terminated

Trial end date:
2010-07-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the long-term safety and tolerability of dimebon in subjects with moderate-to-severe Alzheimer's Disease.

Phase 3

Pfizer

Medivation, Inc.